China · Delayed Price · Currency is CNY Porton Pharma Solutions Statistics
Total Valuation
SHE:300363 has a market cap or net worth of CNY 12.62 billion. The enterprise value is 13.18 billion.
| Market Cap | 12.62B |
| Enterprise Value | 13.18B |
Important Dates
The next estimated earnings date is Saturday, April 4, 2026.
| Earnings Date | Apr 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300363 has 540.16 million shares outstanding. The number of shares has decreased by -1.59% in one year.
| Current Share Class | 540.16M |
| Shares Outstanding | 540.16M |
| Shares Change (YoY) | -1.59% |
| Shares Change (QoQ) | -21.11% |
| Owned by Insiders (%) | 26.98% |
| Owned by Institutions (%) | 8.75% |
| Float | 311.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 101.61 |
| PS Ratio | 3.68 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 2.63 |
| P/FCF Ratio | 73.20 |
| P/OCF Ratio | 23.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.44, with an EV/FCF ratio of 76.40.
| EV / Earnings | -9,356.36 |
| EV / Sales | 3.84 |
| EV / EBITDA | 25.44 |
| EV / EBIT | 133.19 |
| EV / FCF | 76.40 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.87 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 9.99 |
| Interest Coverage | 1.70 |
Financial Efficiency
Return on equity (ROE) is -1.35% and return on invested capital (ROIC) is 1.68%.
| Return on Equity (ROE) | -1.35% |
| Return on Assets (ROA) | 0.71% |
| Return on Invested Capital (ROIC) | 1.68% |
| Return on Capital Employed (ROCE) | 1.43% |
| Weighted Average Cost of Capital (WACC) | 7.48% |
| Revenue Per Employee | 814,227 |
| Profits Per Employee | -334 |
| Employee Count | 4,200 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 3.30 |
Taxes
In the past 12 months, SHE:300363 has paid 60.94 million in taxes.
| Income Tax | 60.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.29% in the last 52 weeks. The beta is 0.71, so SHE:300363's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +48.29% |
| 50-Day Moving Average | 24.47 |
| 200-Day Moving Average | 21.69 |
| Relative Strength Index (RSI) | 36.85 |
| Average Volume (20 Days) | 16,002,056 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300363 had revenue of CNY 3.43 billion and -1.41 million in losses. Loss per share was -0.00.
| Revenue | 3.43B |
| Gross Profit | 942.10M |
| Operating Income | 98.93M |
| Pretax Income | -13.71M |
| Net Income | -1.41M |
| EBITDA | 442.17M |
| EBIT | 98.93M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.33 billion in cash and 1.72 billion in debt, with a net cash position of -395.13 million or -0.73 per share.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 1.72B |
| Net Cash | -395.13M |
| Net Cash Per Share | -0.73 |
| Equity (Book Value) | 5.49B |
| Book Value Per Share | 9.84 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was 537.29 million and capital expenditures -364.83 million, giving a free cash flow of 172.46 million.
| Operating Cash Flow | 537.29M |
| Capital Expenditures | -364.83M |
| Free Cash Flow | 172.46M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 27.46%, with operating and profit margins of 2.88% and -0.04%.
| Gross Margin | 27.46% |
| Operating Margin | 2.88% |
| Pretax Margin | -0.40% |
| Profit Margin | -0.04% |
| EBITDA Margin | 12.89% |
| EBIT Margin | 2.88% |
| FCF Margin | 5.03% |
Dividends & Yields
SHE:300363 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.59% |
| Shareholder Yield | 1.59% |
| Earnings Yield | -0.01% |
| FCF Yield | 1.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 29, 2015. It was a forward split with a ratio of 1.5.
| Last Split Date | Sep 29, 2015 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300363 has an Altman Z-Score of 3.04 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | 6 |